Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat...


Initiation of a Phase 1 clinical trial of VLX-1005 (PRWeb January 14, 2021) Read the full story at https://www.prweb.com/releases/veralox_therapeutics_annou... Read more

Bron: Business
Tags:
Geplaatst: 14 Jan 2021 - 01:00